drug development

R&D

Partner Content

7th Complement-Based Drug Development Summit

With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for

Digital

Short-term crucial to future of AI drug discovery

One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.

Digital

Epiphany moments in an industry starved of insights

Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill.

Market Access

The future of biomedical research is animal-free

Despite the subtle change and lack of immediate impact on patients, the FDA Modernization Act 2.0 is anything but inconsequential, as Pepper Bio's Samantha Dale explains

R&D

Partner Content

4th Cytokine-Based Drug Development Summit

Be part of the only industry focused event exclusively addressing discovery, translational and reverse translational challenges for Cytokine-Based drug developers.

R&D

Partner Content

4th Dermatology Drug Development Summit Europe

The success of the dermatology industry in 2022, with approvals for Alopecia Areata and Vitiligo, brings new opportunity for dermatology drug development.

7th Complement-Based Drug Development Summit

Short-term crucial to future of AI drug discovery

Epiphany moments in an industry starved of insights

The future of biomedical research is animal-free

4th Cytokine-Based Drug Development Summit

4th Dermatology Drug Development Summit Europe

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

drug development

Editor's Picks